Package 70771-1864-6

{"route": ["ORAL"], "spl_id": "b83cc3b5-db55-4fc0-a89d-2cae17fcd445", "openfda": {"unii": ["TP19837BZK"], "rxcui": ["1649485", "1649493"], "spl_set_id": ["246b495a-ea7b-4cbe-9a5f-87c2c0a59cb3"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (70771-1864-6)", "package_ndc": "70771-1864-6", "marketing_start_date": "20240702"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (70771-1864-8)", "package_ndc": "70771-1864-8", "marketing_start_date": "20240702"}], "brand_name": "ivabradine", "product_id": "70771-1864_b83cc3b5-db55-4fc0-a89d-2cae17fcd445", "dosage_form": "TABLET", "pharm_class": ["Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]", "Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]"], "product_ndc": "70771-1864", "generic_name": "ivabradine", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ivabradine", "active_ingredients": [{"name": "IVABRADINE HYDROCHLORIDE", "strength": "7.5 mg/1"}], "application_number": "ANDA213442", "marketing_category": "ANDA", "marketing_start_date": "20240702", "listing_expiration_date": "20261231"}